Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.29 CHF | -0.75% | +0.43% | -5.30% |
04-25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
04-25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.30% | 116M | |
+16.17% | 79.16B | |
+8.46% | 8.72B | |
-16.43% | 4.79B | |
+48.34% | 4.62B | |
+2.91% | 3.82B | |
+14.51% | 2.33B | |
-26.94% | 2.2B | |
+16.55% | 2.1B | |
-36.25% | 2.04B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera Pharmaceuticals, ReveraGen Seek US FDA's New Drug Approval For Vamorolone